About Wessex AHSN
Centre for Implementation Science
Frequently asked questions
Evaluation of national health accelerator identifies key success factors in supporting adoption of innovations in the NHS
The key conditions essential for the adoption and spread of innovations in the NHS have been identified in an independent evaluation of the NHS Inn...
Innovations in Healthcare: Implementation processes, patient experiences, and complex problems, 21st March 2018
Newsletters, annual reports...
Highlights of the event held on 29 November 2017 at the University of Portsmouth.
The AHSN Network is proud to present a new video showcasing the unique role and wide-ranging impact of England’s 15 Academic Health Science Networks (AHSNs). Told in the words of key stakeholders and partners, it sums up in less than 4 minutes how the AHSN Network is enabling the faster spread and adoption of innovation into the NHS in England.
Highlights from the Dorset Health Innovation Forum, held in Bournemouth, on 17 July 2017. This event showcased innovations on the Innovation and Technology Tariff (ITT).
This is a short animation of a selection of our impact from 2016-17.
Anticoagulants are medicines which prevent harmful blood clots, by slightly changing the balance of the natural clotting process. Wessex AHSN has worked closely with several clinical and non-profit organisations to create information resources supporting the use of novel anticoagulants.
There are a number of important things to be aware of when starting anticoagulants. Let's hear from our fictional character Jack as he begins taking this medication and talks about his concerns.
This video showcases why collaboration across the NHS works perfectly for the patient.
We enabled secondary care specialists to work in partnership with GP practices to provide care in the community and ensured a streamline patient journey linked to on-going care by the community pharmacist.